MFP
PFE icon

Meramec Financial Planners’s Pfizer PFE Stock Holding History

Meramec Financial Planners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
8,431
+5,317
+171% +$139K 0.08% 121
2026
Q1 		$85.7K Buy
3,114
+22
+0.7% +$586 0.03% 169
2025
Q4 		$84.2K Buy
+3,092
New +$78K 0.03% 178

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Meramec Financial Planners's PFE Position: Q2 2026 in Review

Meramec Financial Planners increased its Pfizer (PFE) stake by 171% in Q2 2026, buying an estimated $139K and bringing the position to 8,431 shares worth $208K. The position accounts for 0.08% of the portfolio, ranked #121.

Meramec Financial Planners first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Meramec Financial Planners held 8,431 shares of Pfizer worth $208K as of Q2 2026.
  • Meramec Financial Planners bought 5,317 Pfizer shares in Q2 2026, an estimated $139K.
  • Pfizer made up 0.08% of Meramec Financial Planners's portfolio in Q2 2026, its #121 holding.
  • Meramec Financial Planners first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.